MAA
AVNS

Managed Account Advisors’s Avanos Medical AVNS Stock Holding History

Managed Account Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$0 Sell
1
-283
-100% -$12.7K ﹤0.01% 3015
2015
Q1 		$14K Sell
284
-84,073
-100% -$3.89M ﹤0.01% 2788
2014
Q4 		$3.84M Buy
+84,357
New +$3.31M ﹤0.01% 1515

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Managed Account Advisors's AVNS Position: Q2 2015 in Review

Managed Account Advisors reduced its Avanos Medical (AVNS) stake by 100% in Q2 2015, selling an estimated $12.7K and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3015.

Managed Account Advisors first reported a position in AVNS in Q4 2014 and has held it in 3 quarters since. The position peaked at $3.84M in Q4 2014. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

  • Managed Account Advisors held 1 share of Avanos Medical worth $0 as of Q2 2015.
  • Managed Account Advisors sold 283 Avanos Medical shares in Q2 2015, an estimated $12.7K.
  • Avanos Medical made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #3015 holding.
  • Managed Account Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 3 quarters since.
  • Managed Account Advisors's Avanos Medical position peaked at $3.84M in Q4 2014.
  • 419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.